178 related articles for article (PubMed ID: 38439022)
1. Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma.
Xu Y; Hua J; Que H; Zeng T; Li Q; Deng J; Xie J
BMC Cancer; 2024 Mar; 24(1):292. PubMed ID: 38439022
[TBL] [Abstract][Full Text] [Related]
2. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
Jiang Z; Wang J; Dao C; Zhu M; Li Y; Liu F; Zhao Y; Li J; Yang Y; Pan Z
Apoptosis; 2024 Jun; 29(5-6):681-692. PubMed ID: 38281281
[TBL] [Abstract][Full Text] [Related]
3. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
[TBL] [Abstract][Full Text] [Related]
4. A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC.
Wang Y; Zhou J; Zhang N; Zhu Y; Zhong Y; Wang Z; Jin H; Wang X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298343
[TBL] [Abstract][Full Text] [Related]
5. The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Gu Y; Huang Q; Wang Y; Wang H; Xiang Z; Xu Y; Wang X; Liu W; Wang A
BMC Cancer; 2024 Apr; 24(1):420. PubMed ID: 38580922
[TBL] [Abstract][Full Text] [Related]
6. Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Wu Z; Jin M; Xin P; Zhang H
Front Immunol; 2023; 14():1293729. PubMed ID: 38146369
[TBL] [Abstract][Full Text] [Related]
7. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing.
Liu W; Qu C; Wang X
Oncol Res; 2023; 31(4):543-567. PubMed ID: 37415739
[TBL] [Abstract][Full Text] [Related]
9.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
10. A novel PANoptosis-related long non-coding RNA index to predict prognosis, immune microenvironment and personalised treatment in hepatocellular carcinoma.
Wang L; Wan P; Xu Z
Aging (Albany NY); 2024 Jan; 16(3):2410-2437. PubMed ID: 38284890
[TBL] [Abstract][Full Text] [Related]
11. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
Zhuang L; Sun Q; Huang S; Hu L; Chen Q
Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
[TBL] [Abstract][Full Text] [Related]
14. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
Front Immunol; 2022; 13():933241. PubMed ID: 36211378
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based on cytotoxic T lymphocyte evasion gene develops a novel signature to predict prognosis and immunotherapy responses for kidney renal clear cell carcinoma patients.
Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
Front Immunol; 2023; 14():1192428. PubMed ID: 37600786
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
Front Immunol; 2021; 12():657951. PubMed ID: 34531849
[TBL] [Abstract][Full Text] [Related]
18. Identification and experimental validation of PYCARD as a crucial PANoptosis-related gene for immune response and inflammation in COPD.
Shi R; Liang R; Wang F; Wang L; Zidai W; Zhang J; Min L; Du X; Sun S; Xiao C; Li C; Liang X; Chen AF; Yang W
Apoptosis; 2024 Apr; ():. PubMed ID: 38652339
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
[TBL] [Abstract][Full Text] [Related]
20. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy.
Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J
Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
